Lingua: Inglese
Editore: Cham, Springer International Publishing., 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 21,00
Quantità: 2 disponibili
Aggiungi al carrello2015. 235 mm x 155 mm. xiv, 353 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Resistance to Targeted Anti-Cancer Therapeutics ; 7. Sprache: Englisch.
EUR 19,90
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Livraison rapide, bien emballé, service client soigné.Pour tout renseignement complémentaire, n'hésitez pas à nous contacter.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 115,43
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 57,00
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Neuf.
Condizione: New. pp. 353.
Da: Majestic Books, Hounslow, Regno Unito
EUR 158,44
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
EUR 154,97
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 2015 edition. 368 pages. 9.25x6.10x1.10 inches. In Stock.
Lingua: Inglese
Editore: Springer International Publishing, Springer Nature Switzerland, 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 175,74
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 80,52
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 368 | Sprache: Englisch | Produktart: Bücher | This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 179,15
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, 2020
ISBN 10: 0128196092 ISBN 13: 9780128196090
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 175,09
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 189,62
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 193,68
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 206,92
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 201,36
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 214,82
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, US, 2020
ISBN 10: 0128196092 ISBN 13: 9780128196090
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 237,58
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Autophagy in Immune Response: Impact on Cancer Immunotherapy focuses on the status and future directions of autophagy with respect to different aspects of its interaction with the immune system and immunotherapy. The book takes scientific research in autophagy a step further by presenting reputable information on the topic and offering integrated content with advancements in autophagy, from cell biology and biochemical research, to clinical treatments. This book is a valuable source for cancer researchers, oncologists, graduate students and several members of biomedical field who are interested in learning more on the relationship between autophagy and immunotherapies.
Condizione: New. pp. 376.
Da: moluna, Greven, Germania
EUR 197,89
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Presents updated knowledge on autophagy at the basic level and its potential use in cancer treatment Offers the first book to cover autophagy at the interface of cell biology, immunology and tumor biology Provides a wealth of info.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, US, 2020
ISBN 10: 0128196092 ISBN 13: 9780128196090
Da: Rarewaves.com UK, London, Regno Unito
EUR 226,00
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Autophagy in Immune Response: Impact on Cancer Immunotherapy focuses on the status and future directions of autophagy with respect to different aspects of its interaction with the immune system and immunotherapy. The book takes scientific research in autophagy a step further by presenting reputable information on the topic and offering integrated content with advancements in autophagy, from cell biology and biochemical research, to clinical treatments. This book is a valuable source for cancer researchers, oncologists, graduate students and several members of biomedical field who are interested in learning more on the relationship between autophagy and immunotherapies.
Lingua: Francese
Editore: Médecine Science Publications (4/2003), 2003
ISBN 10: 2257114612 ISBN 13: 9782257114617
Da: BOOKIT!, Genève, Svizzera
EUR 87,56
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9782257114617.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer International Publishing Jun 2015, 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 106,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more. 368 pp. Englisch.
Lingua: Inglese
Editore: Springer International Publishing, 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Da: moluna, Greven, Germania
EUR 92,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Explores the inhibition of CTL-cytotoxic function by tumor-derived T-regulatory cells, along with the inhibition of cytotoxic function by tumor induction of hypoxia Discusses the overexpression of transcription factors that regulate resistance.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 137,70
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Majestic Books, Hounslow, Regno Unito
EUR 151,66
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 353.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 152,99
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 353.
Lingua: Inglese
Editore: Palgrave Macmillan, Springer Jun 2015, 2015
ISBN 10: 3319178067 ISBN 13: 9783319178066
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This comprehensive volume explores the latest research on themechanisms of resistance in cancer cells to CTL-mediated immunotherapy.Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order forCTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 368 pp. Englisch.